Rachael L DiSantostefano (R L DiSantostefano)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Rheumatoid Arthritis

Ankylosing Spondylitis

Interstitial Lung Disease

Top Venues

Medical decision making : an international journal of the Society for Medical Decision Making

Scandinavian journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Rachael L DiSantostefano, G Simons, M Englbrecht, Jennifer H Humphreys, Ian N Bruce, Karin Schölin Bywall, C Radawski, K Raza, Marie Falahee, Jorien Veldwijk
Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis. Medical decision making : an international journal of the Society for Medical Decision Making 44 (2) (2024)
Rachael L DiSantostefano, G Simons, M Englbrecht, Jennifer H Humphreys, Ian N Bruce, Karin Schölin Bywall, C Radawski, K Raza, Marie Falahee, Jorien Veldwijk
Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis. Medical decision making : an international journal of the Society for Medical Decision Making (2024)
Rachael L DiSantostefano, G Simons, M Englbrecht, Jennifer H Humphreys, Ian N Bruce, Karin Schölin Bywall, C Radawski, K Raza, Marie Falahee, Jorien Veldwijk
Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis. Medical decision making : an international journal of the Society for Medical Decision Making 44 (2) (2024)
Rachael L DiSantostefano, G Simons, M Englbrecht, Jennifer H Humphreys, Ian N Bruce, Karin Schölin Bywall, C Radawski, K Raza, Marie Falahee, Jorien Veldwijk
Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis. Medical decision making : an international journal of the Society for Medical Decision Making 44 (2) (2024)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Rachael L DiSantostefano, Ian P Smith, Marie Falahee, Aura Cecilia Jimenez-Moreno, Serena Oliveri, Jorien Veldwijk, G Ardine de Wit, Ellen M Janssen, Conny Berlin, Catharina G M Groothuis-Oudshoorn
Research Priorities to Increase Confidence in and Acceptance of Health Preference Research: What Questions Should be Prioritized Now? The patient (2023)
Rachael L DiSantostefano, Ian P Smith, Marie Falahee, Aura Cecilia Jimenez-Moreno, Serena Oliveri, Jorien Veldwijk, G Ardine de Wit, Ellen M Janssen, Conny Berlin, Catharina G M Groothuis-Oudshoorn
Research Priorities to Increase Confidence in and Acceptance of Health Preference Research: What Questions Should be Prioritized Now? The patient 17 (2) (2023)
Rachael L DiSantostefano, Ian P Smith, Marie Falahee, Aura Cecilia Jimenez-Moreno, Serena Oliveri, Jorien Veldwijk, G Ardine de Wit, Ellen M Janssen, Conny Berlin, Catharina G M Groothuis-Oudshoorn
Research Priorities to Increase Confidence in and Acceptance of Health Preference Research: What Questions Should be Prioritized Now? The patient 17 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Rachael L DiSantostefano, Ian P Smith, Marie Falahee, Aura Cecilia Jimenez-Moreno, Serena Oliveri, Jorien Veldwijk, G Ardine de Wit, Ellen M Janssen, Conny Berlin, Catharina G M Groothuis-Oudshoorn
Research Priorities to Increase Confidence in and Acceptance of Health Preference Research: What Questions Should be Prioritized Now? The patient 17 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Karin Schölin Bywall, Matthias Englbrecht, E C Johansson, Rachael L DiSantostefano, Christine A Radawski, Jorien Veldwijk, Karim Raza, Marie Falahee
Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis. Scandinavian journal of rheumatology (2022)
Rachael L DiSantostefano, Fern Terris-Prestholt
Using Societal Values to Inform Public Health Policy During the COVID-19 Pandemic: The Role of Health Preference Research. The patient 14 (3) (2021)
Ian P Smith, Rachael L DiSantostefano, Esther Wilhelmina de Bekker-Grob, Bennett Levitan, Conny Berlin, Jorien Veldwijk, G Ardine de Wit
Methodological Priorities for Patient Preferences Research: Stakeholder Input to the PREFER Public-Private Project. The patient 14 (5) (2021)
Meredith Y Smith, Janine Astrid van Til, Rachael L DiSantostefano, A Brett Hauber, Kevin Marsh
Quantitative Benefit-Risk Assessment: State of the Practice Within Industry. Therapeutic innovation & regulatory science 55 (2) (2020)